Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enzo Biochem 81 Executive Blvd.Suite 3 FARMINGDALE NY 11735 USA

www.enzo.com P: 631-755-5500

Description:

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.

Key Statistics

Overview:

Market Capitalization, $K 55,836
Enterprise Value, $K -26,264
Shares Outstanding, K 51,226
Annual Sales, $ 31,060 K
Annual Net Income, $ 20,290 K
Last Quarter Sales, $ 8,550 K
Last Quarter Net Income, $ -3,060 K
EBIT, $ -9,510 K
EBITDA, $ -6,830 K
60-Month Beta 0.75
% of Insider Shareholders 15.50%
% of Institutional Shareholders 36.90%
Float, K 43,286
% Float 84.50%
Short Volume Ratio 0.17

Growth:

1-Year Return -54.96%
3-Year Return -66.56%
5-Year Return -68.13%
5-Year Revenue Growth -70.34%
5-Year Earnings Growth -112.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 03/13/24
Latest Earnings Date 06/12/24
Earnings Per Share ttm -0.42
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.063 on 06/29/95
Dividend Payout Ratio 0.00%

ENZ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.71%
Return-on-Assets % -22.29%
Profit Margin % 65.33%
Debt/Equity 0.00
Price/Sales 1.86
Price/Cash Flow N/A
Price/Book 0.82
Book Value/Share 1.40
Interest Coverage -0.23

ENZ Dividends

Date Value
06/29/95 $0.0630
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar